【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Key buying criteria
PART 05: Disease overview
• Understanding osteoarthritis
• Etiology and pathophysiology
• Risk factors
• Signs and symptoms
• Diagnosis
• Disease management
• Surgical treatment
• Epidemiology
• Economic burden of osteoarthritis
PART 06: Pipeline portfolio
• Information on pipeline candidates
• Ampion
• Tanezumab
• Zilretta (FX006)
• Fasinumab
• IP 880
• SoluMatrix Naproxen
• ABT-981
• AF-219
• ASP7962
PART 07: Osteoarthritis pain drugs: Clinical trials
PART 08: Opportunities for research in osteoarthritis
• Gaps between current research and possible research issues
• Challenges for vendors involved in osteoarthritis drug development
PART 09: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 10: Market segmentation by drug class
• NSAIDs
• Opioids
• Viscosupplements
• Corticosteroids
• Others
• Global NSAIDs market
• Global opioids market
• Global viscosupplements market
• Global corticosteroids market
PART 11: Market segmentation by ROA
• Oral
• Parenteral
• Topical
PART 12: Market segmentation by dosage form
• Solid
• Liquid
• Semi-solid
PART 13: Geographical segmentation
• Osteoarthritis pain drugs market in Americas
• Osteoarthritis pain drugs market in US
• Osteoarthritis pain drugs market in EMEA
• Osteoarthritis pain drugs market in APAC
PART 14: Market drivers
• Significant unmet medical needs
• Promising drug pipeline
• Increase in prevalence of osteoarthritis and obesity
PART 15: Impact of drivers
PART 16: Market challenges
• Preference for alternative therapies
• Loss of patent exclusivity of branded therapies
• Adverse effects of drugs
PART 17: Impact of drivers and challenges
PART 18: Market trends
• Emergence of new treatments
• Use of off-label drugs
• Strategic alliances
PART 19: Vendor landscape
• Competitive scenario
• Abbott Laboratories
• Johnson & Johnson
• Novartis
• Pfizer
• Other prominent vendors
PART 20: Upcoming vendors with novel approaches
• Ampio Pharmaceuticals
• Flexion Therapeutics
• Kitov Pharmaceuticals
PART 21: Appendix
• List of abbreviations
PART 22: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria
Exhibit 03: Types of osteoarthritis
Exhibit 04: Etiology and pathophysiology of osteoarthritis
Exhibit 05: Signs and symptoms of osteoarthritis
Exhibit 06: Diagnostic test for osteoarthritis
Exhibit 07: Treatment options for osteoarthritis
Exhibit 08: Non-pharmacological therapies used for osteoarthritis
Exhibit 09: Pharmacotherapy therapy for osteoarthritis
Exhibit 10: Surgical treatment
Exhibit 11: Economic burden of osteoarthritis
Exhibit 12: Distribution of direct costs of osteoarthritis
Exhibit 13: Cost analysis of treatment for individuals with osteoarthritis
Exhibit 14: Pipeline molecules for osteoarthritis pain
Exhibit 15: Osteoarthritis clinical trials by development phase
Exhibit 16: Share of Phase I, II, and III pipeline candidates in osteoarthritis pain drugs market
Exhibit 17: Osteoarthritis clinical trials by trial status
Exhibit 18: Highlights of osteoarthritis research opportunities:
Exhibit 19: Global osteoarthritis pain drugs market 2015-2020 ($ billions)
Exhibit 20: Current opportunities of osteoarthritis industry
Exhibit 21: Five forces analysis
Exhibit 22: Global osteoarthritis pain drugs market segmentation by drug class
Exhibit 23: Some NSAIDs used to treat osteoarthritis pain
Exhibit 24: Global osteoarthritis pain drugs market shares by drug class 2015
Exhibit 25: Global osteoarthritis pain drugs market segmentation by drug class 2015-2020 ($ billions)
Exhibit 26: Global osteoarthritis pain drugs market segmentation by drug class 2015-2020 percentage)
Exhibit 27: Global osteoarthritis pain drugs market 2015-2020
Exhibit 28: YoY growth rate of global osteoarthritis pain drugs market segments 2015-2020
Exhibit 29: Global NSAIDs market 2015-2020 ($ billions)
Exhibit 30: Global opioids market 2015-2020 ($ billions)
Exhibit 31: Global viscosupplements market 2015-2020 ($ billions)
Exhibit 32: Global corticosteroids market 2015-2020 ($ billions)
Exhibit 33: Global osteoarthritis pain drugs market segmentation by ROA
Exhibit 34: Global osteoarthritis pain drugs market segmentation by ROA 2015
Exhibit 35: Global osteoarthritis pain drugs market segmentation by dosage form
Exhibit 36: Global osteoarthritis pain drugs market segmentation by ROA 2015
Exhibit 37: Global osteoarthritis pain drugs market by geographical segmentation 2015
Exhibit 38: Global osteoarthritis pain drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 39: Global osteoarthritis pain drugs market revenue by geography 2015-2020
Exhibit 40: Global osteoarthritis pain drugs market: YoY revenue and growth based on geography 2015-2020 ($ billions)
Exhibit 41: Osteoarthritis pain drugs market in Americas 2015-2020 ($ billions)
Exhibit 42: Osteoarthritis pain drugs market in Americas 2015
Exhibit 43: Osteoarthritis pain drugs market in US 2015-2020 ($ billions)
Exhibit 44: Osteoarthritis pain drugs market in EMEA 2015-2020 ($ billions)
Exhibit 45: Osteoarthritis pain drugs market in APAC 2015-2020 ($ billions)
Exhibit 46: Unmet medical needs with current osteoarthritis pain treatments
Exhibit 47: Prevalence of osteoarthritis in 2012 and 2022 (millions)
Exhibit 48: Average annual prevalence of osteoarthritis in US
Exhibit 49: Incidence of osteoarthritis in overweight and normal weight individuals 2013
Exhibit 50: Worldwide estimated osteoarthritis population growth 2010-2020
Exhibit 51: Population aged 60 years and over: World, developed, and developing regions (millions)
Exhibit 52: Expected growth of older population in US 2010-2050
Exhibit 53: Impact of drivers
Exhibit 54: Alternative therapies for osteoarthritis pain
Exhibit 55: Use of CAM therapies among individuals in US
Exhibit 56: Impact of drivers and challenges
Exhibit 57: Future therapeutics in osteoarthritis pain treatment
Exhibit 58: Key takeaways
Exhibit 59: Key takeaways
Exhibit 60: Novartis: YoY revenue and growth rate of Voltaren 2013-2015 ($ millions)
Exhibit 61: Key takeaways
Exhibit 62: Pfizer: YoY revenue and growth rate of Celebrex 2013-2015 ($ millions)
Exhibit 63: Pfizer: Geographical segmentation of Celebrex 2015
Exhibit 64: Key takeaways
Exhibit 65: Flexion Therapeutics: Pipeline products
Exhibit 66: Kitov Pharmaceuticals: Pipeline products
Exhibit 67: Osteoarthritis pain market size model
【レポート販売概要】
■ タイトル：骨関節炎用鎮痛剤の世界市場2016-2020■ 英文：Global Osteoarthritis Pain Market 2016-2020
■ 発行日：2016年5月16日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9464
■ 調査対象地域：グローバル
- 白金採鉱の世界市場（～2020）Global PGM reserves according to Timetric's global platinum report was 2.4 billion ounces in January 2015, with South Africa accounting for 91.4% of this total, followed by Zimbabwe, Russia and the US with 4.1%, 1.6% and 1.3% respectively. The Bushveld Igneous Complex in South Africa and the Great Dyke Mineral belt in Zimbabwe are two of the world’s largest sources of platinum.
- 世界のチタン産業分析：Analyzing the Global Titanium IndustryThe importance of titanium has been growing steadily in the last couple of years. The sheer strength of titanium alloys are unmatchable and are titanium is used widely in the aerospace industry. In fact, the engines of an A380 aircraft used approximately 11 tons of titanium. Apart from the aerospace industry, titanium is used widely in industries such as the automotive industry, chemicals and petr …
- ベビー用ファッション・アクセサリーの世界市場2016-2020About the Baby Fashion Accessories Market In 2015, the clothing accessories segment led the global baby fashion accessories market. Vendors like Gap, Ralph Lauren, and Carter’s have a range of product lines for clothing accessories. Product innovation is one of the most important factors considered by retailers to set competitive advantage. Multifunctional clothing accessories have become a major …
- エプシロン-カプロラクトンの世界市場Epsilon-Caprolactone (CAS 502-44-3) Market Research Report 2013 presents comprehensive data on Epsilon-caprolactone markets globally and regionally (Europe, Asia, North America etc.) The Epsilon-Caprolactone (CAS 502-44-3) Market Research Report 2013 includes Epsilon-caprolactone description, covers its application areas and related patterns. It overviews Epsilon-caprolactone market, names Epsilon …
- グレインミル製品の世界市場：製品種類別（小麦、米、その他）、流通経路別（スーパーマーケット/ハイパーマーケット、食料品店、オンラインストア）Flour is mainly obtained by grinding wheat, maize, rice, and other cereals. Wheat is the grain most commonly used to make flour, accounting nearly 84.5% of the total content, followed by maize (a staple in the Americas) and rice. Wheat is the main ingredient used in the production of bread, which is a staple food for many cultures. Flour contains a high proportion of starch, which is a subset of c …
- アイデンティティ及びアクセス管理の世界市場2016-2020About IAM IAM is a security solution that confirms the accessibility of authorized resources in an IT system. In the mid-1990s, organizations struggled to meet the compliance demands because it was expensive. However, organizations have understood the compliance requirements and are focusing on comply with the set regulations. The key driver for the growth of IAM is the initiatives such as enforce …
- 缶･ペットボトル入り（RTD）お茶とコーヒーの世界市場分析：製品別（缶･ペットボトル入りお茶／コーヒー）、流通経路別（スーパーマーケット/大型スーパーマーケット、コンビニエンスストア、フードサービス）、包装別（缶詰、ガラス瓶、PETボトル）、価格セグメント別（プレミアム、レギュラー、ファウンテン）、セグメント予測、2014-2025The global ready to drink (RTD) tea and coffee market is expected to reach USD 116.13 billion by 2024, according to a new report by Grand View Research, Inc. RTD tea and coffee are a part of the growing trend in the soft drinks industry. These drinks are not only perceived as instant energy drinks but also form a part of lifestyles in major countries around the world. The enhanced nutritional bene …
- 世界の金属鋳造市場動向（2012-2016）TechNavio's analysts forecast the Global Metal Casting market to grow at a CAGR of 7.89 percent over the period 2012-2016. One of the key factors contributing to this market growth is the migration of manufacturing operations to emerging markets. The Global Metal Casting market has also been witnessing the growth of renewable energy castings. However, increasing energy requirements could pose a ch …
- 世界におけるバイオメトリック（生体認証）システム市場2013-2023（地域分析）Synopsis This report offers detailed analysis of the global Biometric System market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Biometric System market. Summary "The Global Biometric System Market 2014-2024 - Country Analysis: Market Profile" provides details of the key markets in each reg …
- ロボット塗装ブースの世界市場2017-2021：塗装ブース、塗装ロボットAbout Robotic Paint Booth Almost every machine, ranging from a small component to an aircraft, requires a coat of paint over the metallic surface to protect it from corrosion. It is this need that makes manufacturers to adopt automated painting technologies in their facilities to ensure health safety of workers, improve throughput, and enhance process efficiency. Automated systems like paint robot …
- 世界のカバン（Luggage、手荷物）市場動向（2014-2018）TechNavio's analysts forecast the Global Luggage market to grow at a CAGR of 7.15 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing consumer income levels. The Global Luggage market has also been witnessing the growing number of marketing initiatives. However, increasing competition from local brands and counterfeit products could pose a …
- 世界の飼料用有機微量ミネラル市場動向（2012-2016）TechNavio's analysts forecast the Global Organic Trace Minerals for Animal Feeds Market to grow at a CAGR of 6.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the Growing Demand for Animal Proteins. The Global Organic Trace Minerals for Animal Feeds Market has also been witnessing an increasing use in water-soluble organic feed additives. However, …
- 糸球体腎炎(Glomerulonephritis)：世界の治験レビュー（2015年上半期版）Glomerulonephritis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Glomerulonephritis Global Clinical Trials Review, H1, 2015" provides data on the Glomerulonephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glomerulonephritis. It includes an overview of the trial numbers and their recruitme …
- グローバル財務会計アプリケーション市場：Global Financial Accounting Application Market?2014-2018TechNavio's analysts forecast the Global Financial Accounting Application market to grow at a CAGR of 3.01 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to improve the operational efficiency and productivity. The Global Financial Accounting Application market has also been witnessing the increasing adoption of cloud-based financial account …
- 光線治療用装置の世界市場予測：ロングランプ、CFL、LED、光ファイバーThe phototherapy equipment market is expected to reach USD 583.4 Million by 2021 from USD 468.2 Million in 2016, growing at a CAGR of 4.5% during the forecast period of 2016 and 2021. This market is primarily driven by the rising incidence of neonatal jaundice in both developed and developing markets, rising number of people suffering from skin diseases, inflow of technologically advanced products …
